Exjade 500 mg Alternative – Deferox (Deferasirox) 500 mg Tablet | Beacon Pharmaceuticals
Deferox 500 mg (Deferasirox) Tablet by Beacon Pharmaceuticals. Reference brand: Exjade. oral iron chelator; used in chronic iron overload requiring chelation. Prescription medicine. Brand comparison does not establish interchangeability.
Product Overview
Deferox 500 mg Tablet is listed in the supplied Beacon Pharmaceuticals anti-cancer and hematology price list. The stated active ingredient is Deferasirox. Exjade is a reference brand for the generic ingredient. This is a product-identification comparison, not a claim of verified bioequivalence or interchangeability.
Deferox vs Exjade – Reference Brand Comparison
Exjade is a recognized reference brand associated with Deferasirox. Deferox is listed under Beacon Pharmaceuticals. Their excipients, marketing authorizations, formulation details and regulatory evidence may differ. A clinician or pharmacist must confirm whether substitution is appropriate.
Composition and Active Ingredient
Brand: Deferox. Active ingredient: Deferasirox. Strength: 500 mg. Dosage form: Tablet. Therapeutic class: oral iron chelator. Listed manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Packaging details should be confirmed on the manufacturer’s current pack.
Therapeutic Uses and Indications
Deferasirox is used in chronic iron overload requiring chelation. These are generic-level clinical contexts and do not independently confirm every indication for this particular branded presentation. Eligibility may depend on biomarkers, previous therapy and country-specific labeling.
Mechanism of Action – How Deferasirox Works
Deferasirox binds excess iron for elimination. This mechanism alone does not establish suitability or effectiveness for an individual patient.
Dosage and Administration
The 500 mg shown is the strength of this tablet, not a recommended daily dose. Dose, timing, food instructions and treatment duration must be determined by the treating specialist using the current authorized prescribing information. Do not change dose or substitute brands or strengths without medical approval.
Contraindications
Contraindications depend on Deferasirox, formulation and individual medical conditions. Review the current official prescribing information, particularly hypersensitivity, pregnancy-related and organ-function restrictions.
Warnings and Precautions
Important safety considerations include kidney injury, liver injury and gastrointestinal bleeding. The prescriber may require laboratory testing, cardiac or organ-function assessment, and ongoing monitoring.
Possible Side Effects
Potential adverse effects and serious reactions include kidney injury, liver injury and gastrointestinal bleeding. Other reactions can occur. Consult the product leaflet for the full adverse-effect profile and seek medical care for severe symptoms.
Drug Interactions
Drug interactions may affect treatment effectiveness or toxicity. Inform the treating clinician of all prescriptions, over-the-counter products, herbal supplements and other treatments.
Pregnancy, Fertility and Breastfeeding
Some oncology and hematology medicines can cause fetal harm and require specific contraception or breastfeeding restrictions. Follow the medicine-specific official labeling and specialist advice.
Storage and Handling
Store according to the instructions printed on the actual Beacon Pharmaceuticals pack. Protect from inappropriate heat, humidity and light, and keep out of reach of children. Do not assume the storage conditions of another brand apply.
Why Is Deferox Listed as an Alternative to Exjade?
The comparison helps identify another listed brand containing Deferasirox. It does not establish identical formulation, regulatory approval, bioequivalence or permission to substitute.
Manufacturer Information
Listed brand: Deferox. Manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Reference brand: Exjade. Generic: Deferasirox. Strength: 500 mg. Dosage form: Tablet.
Frequently Asked Questions
What is Deferox 500 mg? It is a tablet containing Deferasirox 500 mg according to the supplied Beacon price list. What is it used for? Deferasirox is used in chronic iron overload requiring chelation, subject to specialist assessment. Can it replace Exjade? Not automatically; a qualified professional must check product-specific equivalence and regulatory requirements. Is a prescription required? Yes, appropriate prescription and specialist supervision are necessary.
Important Medical Disclaimer
This listing is for educational pharmaceutical identification only and is not a substitute for medical advice, official product labeling or regulatory review. Brand, strength and pack details should be confirmed against the current manufacturer information before dispensing.
| Generic Name | Deferasirox |
|---|---|
| Strength | 500 mg |
| Manufacturer | Beacon Pharmaceuticals Ltd. |
Related products
Gleevec / Glivec 400 mg Alternative – Imacent (Imatinib) 400 mg Tablet | Incepta Pharmaceuticals
Imacent 400 mg (Imatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Gleevec / Glivec (Novartis).
Pack: 30 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Jakafi / Jakavi 5 mg Alternative – Rulicent (Ruxolitinib) 5 mg Tablet | Incepta Pharmaceuticals
Rulicent 5 mg (Ruxolitinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Jakafi / Jakavi (Incyte / Novartis).
Pack: 14 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Purinethol 50 mg Alternative – Leukin (Mercaptopurine) 50 mg Tablet | Beacon Pharmaceuticals
Revlimid 10 mg Alternative – Linamide (Lenalidomide) 10 mg Capsule | Beacon Pharmaceuticals
Rituxan / MabThera 500 mg Alternative – Relyto (Rituximab) 500 mg IV infusion | Incepta Pharmaceuticals
Relyto 500 mg (Rituximab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Rituxan / MabThera (Roche / Genentech).
Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Reviews
There are no reviews yet.